Showing results (1581-1590 of 2,586) with videos related to

Sort By:
Pageof 259
Molecular Oncology|April 13, 2015
Comprehensive analysis of microRNA expression profile in malignant glioma tissuesMonika Piwecka, Katarzyna Rolle, Agnieszka Belter, et al.
Molecular Oncology|July 18, 2020
Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transitionXue Zhang, Jian Bai, Hang Yin, et al.
Molecular Oncology|July 21, 2020
Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinomaMiao Li, Chen Zhang, Lijun Zhou, et al.
Molecular Oncology|April 25, 2023
Prognostic association of immunoproteasome expression in solid tumours is governed by the immediate immune environmentRahul Kumar, Bhavya Dhaka, Sarthak Sahoo, et al.
Molecular Oncology|April 14, 2023
Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapyMattea Reinisch, Simona Bruzas, Oleg Gluz, et al.
Molecular Oncology|January 7, 2014
Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cellsHua Jiang, Wenhao Zhang, Peipei Shang, et al.
Molecular Oncology|January 7, 2014
Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft modelSifeng Qu, Kendric Wang, Hui Xue, et al.
Molecular Oncology|November 1, 2012
Topoisomerase 1(TOP1) gene copy number in stage III colorectal cancer patients and its relation to prognosisMaria Unni Rømer, Sune Boris Nygård, Ib Jarle Christensen, et al.
Molecular Oncology|November 14, 2012
Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KITSabrina Brahimi-Adouane, Jean-Baptiste Bachet, Séverine Tabone-Eglinger, et al.
Molecular Oncology|November 15, 2012
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunityLetizia Porcelli, Anna E Quatrale, Paola Mantuano, et al.
Pageof 259